MuSigmas logo.
  • Home
  • Team
  • Expertise & Services
    • Adaptive Designs
    • Bayesian Statistics and Bayesian Designs
    • Regulatory Defence of Protocols and Study Designs
    • Master Protocol Study Designs
    • Simulation Guided Designs
    • Diagnostics Development and Validation
    • Design of Vaccine Trials
    • Strategies for Real World Evidence (RWE) and Post-marketing studies
    • Data Safety Monitoring Committee (DMC/DSMB) Services
    • Statistical Programming using R/Python
    • Training in Adaptive Designs and Bayesian Statistics
    • Machine Learning (ML) Applications for Biomarker Discoveries and Diagnostics
    • R/Python package validation capabilities
    • Therapeutic Areas / Diseases
  • Case Studies
    • Saving Time and Resources in Clinical Trials with Adaptive Designs
  • News
  • Blogs
    • Intern Corner
  • Contact

MuSigmas

We empower clinical trialists to design faster, cost-effective, and regulatory-compliant trials through advanced statistical strategies.

We offer statistical planning and regulatory support for early- and late-phase clinical trials and observational studies, with expertise in Adaptive Designs including Bayesian Designs, as well as the application of machine learning for biomarker discoveries and diagnostic device development. In addition to design and analysis, we offer support in regulatory defense for clinical trial designs and protocols, and Data Monitoring Committee (DMC) related services. While we cover all therapeutic areas, we have extensive experience in Oncology, CVD, CNS, rare diseases, vaccine trials and medical devices. We are also actively involved in developing cutting-edge statistical tools and software to empower statisticians, data scientists and clinicians.

Planning for a clinical trial? Mitigate trial risk and increase efficiency with robust statistical planning — partner with us.

Discover how




  • 2025 MuSigmas Consultants S.L.